Skip to content

The Effect of Reiki Therapy in Pediatric Oncology Patients

The Effect of Reiki Therapy on Pain, Vital Signs and Quality of Life in Pediatric Oncology Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05698953
Enrollment
66
Registered
2023-01-26
Start date
2020-12-01
Completion date
2023-03-01
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reiki

Keywords

Reiki Touch Therapy, Pediatric Oncology, Pain, Quality of Life, Vital Signs

Brief summary

The study was conducted based on randomized controlled experimental design with double-blind, pre-test-post-test to determine the effect of Reiki applied to pediatric oncology patients aged 5-7 years on pain, vital signs, oxygen saturation (SpO2) and quality of life. While the population of the study consisted of oncology patients aged 5-7 years who were hospitalized in the pediatric oncology services between December 2020 and November 2021, the sample consisted of 66 children diagnosed with leukemia who met the sample selection criteria. The research consists of 3 groups. These groups are Reiki group (n=22), Placebo group (n=22), control group (n=22). The data are collected using Introductory Information Form, Wong-Baker FACES Pain Scale (W-BPS), Vital Signs Follow-up Form, The Pediatric Quality of Life Inventory (PedsQL) 3.0 Cancer Module Child and Parent Form. Reiki was applied to the Reiki group for 20-30 minutes for three consecutive days and Placebo was applied to the sham Reiki group by an independent nurse during the same application period. The children in the control group were like the routine of the ward.

Detailed description

The universe of the study consisted of pediatric oncology patients who met the selection criteria in the pediatric oncology services. The study was planned as a randomized controlled experimental design with double-blind, pre-test post-test to determine the effect of Reiki applied to pediatric oncology patients aged 5-7 years on pain, vital signs, oxygen saturation (SpO2) and quality of life. In order for the groups to be distributed homogeneously, the order produced by a computer program (http://www.randomization.com , Balanced permutation) was used. Patients who meet the inclusion criteria and agree to participate in the study assigned to the experimental and control groups according the randomization list. The control variable of the study is demographic characteristics of the children. The dependent variables of the study are pain, vital signs, oxygen saturation parameters and quality of life score.

Interventions

OTHERReiki

Reiki is applied to the Reiki group for 20-30 minutes for three consecutive days.

OTHERPlacebo

Placebo group is applied to the sham Reiki group for 20-30 minutes for three consecutive days by an independent nurse during the same application period.

Sponsors

University of Yalova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

The research consists of 3 groups. These groups are Reiki group, Placebo group, control group.

Intervention model description

The study are conducted based on randomized controlled experimental design with double-blind, pre-test-post-test to determine. The research consists of 3 groups. These groups are Reiki group, Placebo group, control group.

Eligibility

Sex/Gender
ALL
Age
5 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Being treated in the pediatric oncology service at the time of the study * Being between 5-7 years old * Body temperature being within normal limits * To have received at least 1 course of chemotherapy * Absence of visual, auditory problems or mental retardation at a level that can fill the scales,

Exclusion criteria

* To have taken analgesic medication in the last 6 hours, * Have received any energy and body-mind therapy (yoga, reiki, massage, meditation, healing touch) in the last six months

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the pain score values of the groupsChildren's pain levels will be evaluated on the 1st day.The Wong-Baker Faces Pain Scale revised (W-BFS) was used to determine the level of pain during the procedure. The W-BFS is a scale that is most commonly used in identifying pain in children of the ages 3 to 18. It is reported that the scale is reliable when used with children older than the age of 3 who can verbally express the degree of pain they feel. The scale is made up of faces and numbers. Pain is assessed on a scale of 0 to 10. Pain is described by selecting the facial expression depicting the degree of perceived pain.
Comparison of the heart rate values of the groupsChildren's heart rate values will be evaluated on the 1st day.Finger type portable Creative PC 60 pulse oximeter device was used to measure the heart rate values of the children.
Comparison of the respiratory rate values of the groupsChildren's respiratory rate values will be evaluated on the 1st day.The respiratory rate values of the children will be measured by counting for 1 minute.
Comparison of the body temperature values of the groupsChildren's body temperature values will be evaluated on the 1st day.Cem brand infrared thermometer device was used to measure body temperature of the children.
Comparison of the oxygen saturation values of the groupsChildren's oxygen saturation values will be evaluated on the 1st day.Finger type portable Creative PC 60 pulse oximeter device was used to measure the oxygen saturation values of the children.
Comparison of Groups' Quality of Life Scale (PedsQL 3.0 Cancer Module) ScoresMeasurements will be made before on the 1st and after 3rd days the intervention.The Child and Parent Reports of the PedsQL 3.0 Cancer Module for Young Children (ages 5-7), are composed of 26 items comprising 8 dimensions. Scores are transformed on a scale from 0 to 100. Items are reversed scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, 4=0. Higher scores indicate lower problems.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026